WO2000057184A3 - Screening methods based on fha domains - Google Patents
Screening methods based on fha domains Download PDFInfo
- Publication number
- WO2000057184A3 WO2000057184A3 PCT/GB2000/001024 GB0001024W WO0057184A3 WO 2000057184 A3 WO2000057184 A3 WO 2000057184A3 GB 0001024 W GB0001024 W GB 0001024W WO 0057184 A3 WO0057184 A3 WO 0057184A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- screening methods
- methods based
- fha domains
- interaction
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU34407/00A AU3440700A (en) | 1999-03-19 | 2000-03-17 | Assays, methods and means |
EP00912756A EP1163521A2 (en) | 1999-03-19 | 2000-03-17 | Assays, methods and means |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9906432.1 | 1999-03-19 | ||
GBGB9906432.1A GB9906432D0 (en) | 1999-03-19 | 1999-03-19 | Assays,methods and means |
GBGB9915075.7A GB9915075D0 (en) | 1999-03-19 | 1999-06-28 | Assays,methods and means |
GB9915075.7 | 1999-06-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000057184A2 WO2000057184A2 (en) | 2000-09-28 |
WO2000057184A3 true WO2000057184A3 (en) | 2001-03-08 |
Family
ID=26315311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/001024 WO2000057184A2 (en) | 1999-03-19 | 2000-03-17 | Screening methods based on fha domains |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1163521A2 (en) |
AU (1) | AU3440700A (en) |
GB (1) | GB2348701B (en) |
WO (1) | WO2000057184A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6660511B1 (en) * | 2000-03-03 | 2003-12-09 | Rigel Pharmaceuticals, Inc. | Methods of screening for modulation of cell cycle |
EP1949894B1 (en) * | 2007-01-25 | 2016-06-29 | Roche Diagnostics GmbH | Enhancement of vanadium-containing phosphatase inhibitors by polyols |
US8008035B2 (en) | 2007-01-25 | 2011-08-30 | Roche Diagnostics Operations, Inc. | Enhancement of vanadium-containing phosphatase inhibitors |
US10370776B2 (en) * | 2013-09-25 | 2019-08-06 | Idea Orchard, Llc | Antibody like protein |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763164A (en) * | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
WO1999042833A1 (en) * | 1998-02-19 | 1999-08-26 | Imperial Cancer Research Technology Limited | Protein kinase c |
-
2000
- 2000-03-17 AU AU34407/00A patent/AU3440700A/en not_active Abandoned
- 2000-03-17 EP EP00912756A patent/EP1163521A2/en not_active Withdrawn
- 2000-03-17 WO PCT/GB2000/001024 patent/WO2000057184A2/en not_active Application Discontinuation
- 2000-03-17 GB GB0006533A patent/GB2348701B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763164A (en) * | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
WO1999042833A1 (en) * | 1998-02-19 | 1999-08-26 | Imperial Cancer Research Technology Limited | Protein kinase c |
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
GB2348701A (en) | 2000-10-11 |
EP1163521A2 (en) | 2001-12-19 |
GB0006533D0 (en) | 2000-05-10 |
AU3440700A (en) | 2000-10-09 |
WO2000057184A2 (en) | 2000-09-28 |
GB2348701B (en) | 2001-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002302713A1 (en) | Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof | |
NZ513680A (en) | Epitodes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses | |
WO2001057198A3 (en) | Methods of generating protein expression arrays and the use thereof in rapid screening | |
WO2000063247A3 (en) | Osteopontin-derived chemotactic and inhibitory agents and uses therefor | |
AU9222698A (en) | Novel molecules of the tnfr-ligand-related protein family and uses thereof | |
AU2002227279A1 (en) | Polynucleotide and polypeptide sequences of putative transporters and ion channells | |
AU3365499A (en) | Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof | |
WO1998057983A3 (en) | Mammalian neuro-growth factor like protein | |
WO2006024020A3 (en) | Hcv non-structural protein mutants and uses thereof | |
WO2001042277A3 (en) | Complementary peptide ligands generated from the human genome | |
WO2000057184A3 (en) | Screening methods based on fha domains | |
AU3749499A (en) | Novel molecules of the bgckr-related protein family and uses thereof | |
AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
WO2000018909A3 (en) | NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) | |
AU2002245371A1 (en) | Novel molecules of the pyrin/nbs/lrr protein family and uses thereof | |
WO2001042287A3 (en) | Putative human g-protein coupled receptors | |
EP1183268A4 (en) | LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES | |
AU4397097A (en) | Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation | |
EP1181315A4 (en) | LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES | |
AU2002362414A1 (en) | Novel molecules of the hkid-1-related protein family and uses thereof | |
AU1657501A (en) | Determining the functions and interactions of proteins by comparative analysis | |
HK1039636A1 (en) | Myelin basic protein peptides and uses thereof | |
AU5563699A (en) | Analogs of udp-murnac peptides, assays and kits | |
AU4729499A (en) | Oct1p, a protein having homology to the organic and sugar transporter family of proteins, and uses thereof | |
AU2001259420A1 (en) | Novel molecules of the nbs/lrr protein family and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000912756 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09936956 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000912756 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000912756 Country of ref document: EP |